Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 25,704 | 22,079 | 18,262 | 16,491 | 14,826 |
| Operating Income | -25,704 | -22,079 | -18,262 | -16,491 | -14,826 |
| Other Income | 2,866 | 2,664 | 764 | 424 | 166 |
| Pre-tax Income | -22,838 | -19,415 | -17,498 | -16,067 | -14,660 |
| Net Income Continuous | -22,838 | -19,415 | -17,498 | -16,067 | -14,660 |
| Net Income | $-22,838 | $-19,415 | $-17,498 | $-16,067 | $-14,660 |
| EPS Basic Total Ops | -0.36 | -0.30 | -0.34 | -0.32 | -0.30 |
| EPS Basic Continuous Ops | -0.36 | -0.30 | -0.34 | -0.32 | -0.30 |
| EPS Diluted Total Ops | -0.36 | -0.30 | -0.34 | -0.32 | -0.30 |
| EPS Diluted Continuous Ops | -0.36 | -0.30 | -0.34 | -0.32 | -0.30 |
| EBITDA(a) | $-27,538 | $-23,742 | $-17,970 | $-15,922 | $-14,029 |